Advanced Medical Nutrition Therapy - II Comprehensive Study Guide
FNC507A Medical Nutrition Therapy - II: Course Summary and Outcomes
- Programme: M.Sc. Food Nutrition and Dietetics
- Department: Food Technology (Faculty of Life and Allied Health Sciences)
- Course Leader: Dr. Bhavana S
- Course Aim: To provide an evidence-based medical approach to screening, assessing, and treating various medical conditions including Morbid Obesity, Eating Disorders, Diabetes Mellitus, Renal Diseases, PCOS, Thyroid Disorders, Cardiovascular Diseases (CVDs), Cancer, and HIV/AIDS.
- Learning Outcomes:
- Understand the preventive and therapeutic roles of diet in chronic degenerative diseases.
- Analyze etiology, diagnosis, and pathophysiology of non-communicable diseases (NCDs).
- Recommend nutritional care based on pathophysiology and prevent diet-related disorders.
- Understand advances in emerging modes of therapy and ongoing field research.
Unit I: Medical Nutrition Therapy for Obesity and Weight Management
- Definitions:
- Obesity: A treatable disease and worldwide health concern associated with an excess amount of body fat.
- WHO Definition: Abnormal or excessive fat accumulation that presents a risk to health.
- BMI (Body Mass Index): A weight-for-height index calculated as weight(kg)/height(m)2.
- Overweight: BMI≥25.0kg/m2
- Obesity: BMI≥30.0kg/m2
- Childhood Obesity: For children under 5, overweight is >2 standard deviations (SD) above the WHO median; obesity is >3 SD above the median.
- Types of Obesity:
- Developmental Obesity: Begins early in life, continuing into adulthood. Fat cells become saturated; foundation set by age 4. Results in higher lean body mass along with fat due to skeletal support for weight.
- Reactive Obesity: Develops due to emotional stress periods. Weight reflects intermittent ups and downs. Results in more lean mass relative to fat content.
- Physiological & Genetic Factors:
- Genes: The ob gene (produces leptin, the satiety hormone) and the β3-adrenoreceptor gene (located in adipose tissue, regulates resting metabolic rate and fat oxidation). Mutations in either can lead to weight gain.
- Adipose Tissue:
- WAT (White Adipose Tissue): The body’s energy reserve; stores fat, cushions organs, and acts as insulation.
- BAT (Brown Adipose Tissue): The body’s heat generator; burns calories for thermogenesis.
- Hormonal Regulation:
- Leptin: Satiety hormone produced by fat cells. Obese individuals often face leptin resistance.
- Ghrelin: Hunger hormone produced by the stomach; stimulates appetite.
- Adiponectin: Regulates glucose and insulin sensitivity; levels are lower in obese individuals.
- Assessment Methods:
- Waist Circumference: High risk is >102cm for men and >88cm for women (>90cm and >80cm for Asian males/females respectively).
- Waist-Hip Ratio (WHR): Indicator of abdominal obesity if >1.0 (men) or >0.85 (women).
- Android Obesity: Upper trunk/central fatness.
- Gynoid Obesity: Lower trunk (hip/buttocks) fatness.
- Weight Management Theories:
- Plateau Effect: Weight loss slows as glycogen and water are lost, then extra muscle mass is lost, reducing the Resting Metabolic Rate (RMR).
- Set-Point Theory: The point where weight loss stops unless nutritional intake or physical activity is changed.
- Yo-yo Effect (Weight Cycling): Repeated losing and gaining. Regaining weight happens faster and losing it becomes harder over time.
- Surgical Options (Bariatric Surgery): Indicated for BMI≥40 or BMI≥35 with comorbidities.
- Gastric Bypass: Current gold standard; creates a tiny stomach pouch.
- Gastroplasty: Using staples to create a small opening into the distal stomach.
- Jejuno-ileal Bypass: Reduces the absorptive surface of small intestines.
- Jaw Wiring: Permits only liquid intake via straw.
- Liposuction: Cosmetic procedure involving aspiration of subcutaneous fat.
- Underweight Management:
- Definition: BMI<18.5kg/m2 or 10−20%below average expected weight.
- Etiology: Hyperthyroidism, malabsorption, or genetic predisposition.
- MNT: Energy intake 500−1000Kcal/day in excess of needs. Protein at 1.2g/kg/day. Fats at 30%ofcalories.
Unit II: Medical Nutrition Therapy for Cardiovascular Diseases (CVD)
- Atherosclerosis: A slow, progressive disease where fatty deposits (plaque) thicken the intima (innermost coat of artery).
- Ischemia: Inadequate oxygen supply due to reduced blood flow, causing Angina Pectoris (chest pain radiating to the left arm).
- Phases of Atherosclerosis: Phase 1 (asymptomatic fatty streaks), Phase 2 (plaque rupture-prone), Phase 3 (acute with non-occlusive thrombus), Phase 4 (occlusive thrombus/MI), Phase 5 (fibrotic lesion).
- Hypertension (HT): Called the "silent killer."
- Systolic (SBP): Pressure during contraction (Lup).
- Diastolic (DBP): Pressure during relaxation (Dup).
- Classifications (ACC/AHA):
- Normal: <120/80mmHg
- Elevated: 120−129/<80mmHg
- Stage 1: 130−139/80−89mmHg
- Stage 2: ≥140/90mmHg
- Crisis: ≥180/120mmHg
- Heart Failure (HF/CHF): The heart cannot pump enough blood to meet metabolic needs.
- Cardiac Cachexia: Unintentional severe weight loss caused by heart failure; requires high-calorie intake.
- MNT for Heart Failure: Small frequent meals; restrict sodium (1−2g/day); restrict fluids only if edema is present.
- Diagnostic Tools: ECG (electrical signals), Echocardiogram (ultrasound), Stress Test (Treadmill), and Coronary Angiography (iodine contrast X-ray).
- Dietary Approaches:
- DASH Diet: High in Potassium, Calcium, and Magnesium; limits sodium to 2300mg/day.
- Mediterranean Diet: Focuses on plant-based foods, Extra Virgin Olive Oil (EVOO), and moderate fish (Omega-3 fatty acids).
- Inflammatory Markers: C-Reactive Protein (CRP) is a primary biomarker; high levels indicate systemic inflammation and higher cardiac risk.
Unit III: Medical Nutrition Therapy for Diabetes Mellitus
- Definition: A group of diseases characterized by hyperglycemia resulting from insulin secretion/action defects.
- Type 1 (IDDM): Autoimmune destruction of islet β-cells; requires exogenous insulin.
- Type 2 (NIDDM): Insulin resistance and relative insulin deficiency; linked to obesity/lifestyle.
- Type 3 (MRDM): Malnutrition Related Diabetes Mellitus; common in developing countries for ages 15-30.
- Gestational Diabetes (GDM): Diagnosed for the first time during pregnancy; increases risk for T2DM later.
- Diagnosis Criteria (ADA):
- Fasting Plasma Glucose (FPG): Diabetes at ≥126mg/dL.
- Oral Glucose Tolerance Test (OGTT/GTT): 2-hour value ≥200mg/dL after 75g glucose.
- HbA1C: Diabetes at ≥6.5%.
- Theories of Prognosis:
- Thin-Fat Phenotype: Common in India/China; normal BMI but high body fat percentage.
- Thrifty Gene Hypothesis: Genetic basis for efficient fat storage for survival during scarcity, now harmful in sedentary lifestyles.
- Carbohydrate-Insulin Model (CIM): Postulates that processed carbs shift energy deposition to adipose tissue.
- MNT & Management:
- Protein: 10−15%oftotalcalories.
- Fiber: 20−30g/day (soluble fiber slows glucose absorption).
- Glycemic Index (GI): Low (≤55), Medium (56−69), High (≥70).
- Carbohydrate Counting: Matching insulin dose to carbohydrate intake. 1 carb exchange = 15g of carbohydrate.
- Acute Complications: Diabetic Ketoacidosis (DKA - fruity breath/ketones), Hypoglycemia (shakiness/sweating), and Diabetic Coma.
Unit IV: Medical Nutrition Therapy for Renal Disorders
- Kidney Functions: Filtration (urine formation), Excretion (urea/uric acid), Endocrine (Erythropoietin for RBCs, Renin for BP, Calcitriol for Vitamin D activation).
- Assessment: Glomerular Filtration Rate (GFR) is the ideal marker. Normal clearance is ≈125ml/min.
- Albuminuria: Principal marker of kidney damage; protein in urine.
- Diseases:
- Glomerulonephritis: Inflammation of glomeruli often post-streptococcal infection. Require energy-dense, protein-sparing diet (30−40Kcal/kg; 0.5−0.6g/kg protein initially).
- Nephrotic Syndrome: Massive proteinuria and edema. Goal: correct protein deficiency and manage sodium (1−2g/day).
- AKI (Acute Kidney Injury): Sudden loss of excretory function. Treated as a medical emergency.
- CKD (Chronic Kidney Disease): Progressive damage. Stage 5 is ESRD (End-Stage Renal Disease) where GFR<15ml/min.
- Dialysis Types:
- Hemodialysis (HD): External filtering 3 days/week; requires 1.0−1.2g/kg protein.
- Peritoneal Dialysis (PD): Uses the peritoneum as a filter; requires higher protein (1.2−1.3g/kg) due to losses in dialysate.
- Thyroid Hormones: Triiodothyronine (T3) and Thyroxine (T4). Iodine is vital for synthesis (150μg/day min).
- HPT Axis: Hypothalamus (TRH) → Pituitary (TSH) → Thyroid (T3/T4) negative feedback loop.
- OAT Axis: Relationship between Ovaries, Adrenal, and Thyroid glands.
- Disorders:
- Hypothyroidism: Underactive thyroid (e.g., Hashimoto’s disease - autoimmune). Symptoms: weight gain, cold intolerance, constipation.
- Hyperthyroidism: Overactive thyroid (e.g., Graves’ disease - autoimmune). Symptoms: weight loss, bulging eyes (exophthalmos), heat intolerance.
- PCOS (Polycystic Ovary Syndrome): Endocrine disorder in women featuring cysts, androgen excess, and insulin resistance. MNT focuses on low-GI diet and weight management.
Unit VI: Medical Nutrition Therapy for Cancer
- Carcinogenesis Stages: Initiation (irreversible genetic mutation), Promotion (reversible growth/division), Progression (invasion), and Metastasis (spread to distant organs).
- Food Carcinogens: Aflatoxins (moldy nuts), HCAs (charred meats), Nitrosamines (processed meats), and Acrylamide (burnt starchy foods).
- Cancer Cachexia: Severe wasting of muscle and fat; hypermetabolic state with energy needs of 30−35Kcal/kg/day.
- MNT: High-protein (1.2−2.0g/kg), high-energy. Focus on phytonutrients (Curcumin in turmeric, Lycopene in tomatoes, Sulforaphane in broccoli).
Unit VII: Medical Nutrition Therapy for HIV and AIDS
- HIV (Human Immunodeficiency Virus): Retrovirus targeting CD4+ T cells.
- Stages: Stage 1 (Acute), Stage 2 (Latency), Stage 3 (Symptomatic), Stage 4 (AIDS: CD4<200cells/mm3).
- AIDS Wasting Syndrome: Unintentional weight loss >10%, chronic diarrhea/weakness for >30 days.
- MNT:
- Increase energy needs by 10−30%.
- Protein: 1.2−2.0g/kg/day.
- Treatment: ART (Antiretroviral Therapy), formerly HAART.
- Special Considerations: For women/children, focus on preventing mother-to-child transmission (PMTCT), managing breastfeeding (exclusive for 6 months if ART available), and supporting growth milestones.
Practicals & Assessment
- Interpretation of diagnostic biomarkers.
- Assessment and management of underweight and obesity.
- Diet planning for CVD using the DASH approach.
- Carbohydrate counting and low-carb recipes.
- Diet planning for T2DM and its long-term complications.
- Development of low sodium and potassium recipes.
- Nutritional management of renal diseases.
- Management for Hypothyroidism and PCOS.
- Dietary management for underweight Cancer/AIDS patients.
- Assessment Weightage: Midterm Exam (25%), Assignment (25%), Semester End Exam (50%).